These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic? Lue LF; Schmitz C; Walker DG Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879 [TBL] [Abstract][Full Text] [Related]
11. Microglia heterogeneity and neurodegeneration: The emerging paradigm of the role of immunity in Alzheimer's disease. Hashemiaghdam A; Mroczek M J Neuroimmunol; 2020 Apr; 341():577185. PubMed ID: 32045774 [TBL] [Abstract][Full Text] [Related]
12. Vps35-dependent recycling of Trem2 regulates microglial function. Yin J; Liu X; He Q; Zhou L; Yuan Z; Zhao S Traffic; 2016 Dec; 17(12):1286-1296. PubMed ID: 27717139 [TBL] [Abstract][Full Text] [Related]
13. Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets. Nizami S; Hall-Roberts H; Warrier S; Cowley SA; Di Daniel E Br J Pharmacol; 2019 Sep; 176(18):3515-3532. PubMed ID: 30740661 [TBL] [Abstract][Full Text] [Related]
15. [Roles of microglia and immune receptors in Alzheimer's disease]. He X; Sun BG Yao Xue Xue Bao; 2014 Jun; 49(6):774-80. PubMed ID: 25212020 [TBL] [Abstract][Full Text] [Related]
16. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. Neumann H; Takahashi K J Neuroimmunol; 2007 Mar; 184(1-2):92-9. PubMed ID: 17239445 [TBL] [Abstract][Full Text] [Related]
17. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice. Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771 [TBL] [Abstract][Full Text] [Related]
18. TREM2 sustains microglial expansion during aging and response to demyelination. Poliani PL; Wang Y; Fontana E; Robinette ML; Yamanishi Y; Gilfillan S; Colonna M J Clin Invest; 2015 May; 125(5):2161-70. PubMed ID: 25893602 [TBL] [Abstract][Full Text] [Related]
19. [Neurodegenerative disease and TREM2]. Takahashi K Rinsho Shinkeigaku; 2014; 54(12):1122-4. PubMed ID: 25519966 [TBL] [Abstract][Full Text] [Related]
20. Triggering receptor expressed on myeloid cells-2 is involved in prion-induced microglial activation but does not contribute to prion pathogenesis in mouse brains. Zhu C; Herrmann US; Li B; Abakumova I; Moos R; Schwarz P; Rushing EJ; Colonna M; Aguzzi A Neurobiol Aging; 2015 May; 36(5):1994-2003. PubMed ID: 25816748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]